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Conclusion  
Real-time dose reconstruction to moving tumours was 
developed and showed promising results for liver SBRT. 
The dose reconstruction allows immediate evaluation of 
the treatment quality. It could, for example, be used to 
trigger more elaborate dose analysis and plan adaptation 
in case of large motion-induced dose degradation. 
Ongoing work will extend DoseTracker with CT 
heterogeneities and include all 15 patients of the gating 
study. 
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Purpose or Objective  
Dose fractionation, normalization and the dose profile 
inside the target volume varies significantly between 
different institutions and methods for lung SBRT. A 
comparison of dosimetric as well as outcome data 
amongst institutions is therefore difficult. Published 
planning studies have shown that, despite dose 
prescription on the covering isodose of the PTV, the 
mean dose in PTV and ITV varied significantly, in 
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particular when comparing different dose delivery 
techniques. This multi-center planning study of the 
DEGRO AG Stereotactic Radiotherapy investigated 
whether a prescription on the mean ITV dose results in 
more comparable dose distributions among participating 
centers and methods. 
Material and Methods  
CT images and structures of ITV, PTV and all relevant 
OAR for two patients with early stage NSCLC were sent to 
all participating institutions. Each institute created a 
treatment plan with the technique commonly used in the 
institute for lung SBRT.  
The specified dose fractionation was 3x21.5 Gy 
normalized to the mean ITV dose, this corresponds to 
3x15Gy on the 65% isodose. Other constraints on ITV, PTV 
and OAR are giben in Tab. 1. 
 
 
 
Kruskal-Wallis test was used to compare results for PTV 
and GTV doses between different delivery techniques. 
Results  
57 plans from 27 institutions could be collected. These 
contained 8 Robotic Radiosurgery (RRS), 34 modulated 
plans (MOD), and 15 3D conformal (3D) plans. Only one 
plan could not fulfill the given constraints (high 
conformity index) while in 18 cases there was a minor 
deviation.  
Due to the normalization the mean ITV dose was identical 
in all cases and the median dose in the ITV varied only 
marginally (64.1-65.7 Gy).  For both patients the median 
coverage of the ITV with the 90% Isodose was above 98% 
(94.2-100%). 
The median of the mean dose in the PTV did not differ 
significantly between the two patients (56.9 Gy vs 56.6 
Gy). There was only a small difference between the 
techniques, with RRS having the lowest mean PTV Dose 
with 55.9 Gy followed by MOD plans with 56.7 Gy and 3D 
plans with 57.5 Gy having the highest as shown in Fig. 1. 
 
 
 
The Coverage of the PTV with the 70% Isodose (= 45Gy) 
showed no significant variation between the techniques 
however it was planner dependent (90-100%), with four 
plans being below 95% coverage (3 MOD and 1 3D plan). 
No significant difference could be found between the 
conformity indices. It was slightly lower for robotic 
radiosurgery and modulated plans (median 1.12) than for 
3D conformal plans (median 1.18).  
For the different organs at risks no significant difference 
between the techniques could be found. 
Conclusion  
This planning study showed that normalization on the 
mean ITV dose in combination with detailed constraints 
for the PTV and ITV can lead to consistent dose 
distributions for different delivery techniques. The only 
significant difference found was the mean PTV dose, but 
the difference was small.  
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Purpose or Objective  
The interplay between respiratory motion of a tumor and 
dose delivered by complex radiotherapy techniques like 
VMAT can potentially lead to undesirable and non-
intuitive deviations from the planned dose distribution. 
We developed a 4D dose recalculation framework to 
precisely simulate the dose distribution for a moving 
target volume. A wide range of breathing scenarios has to 
be explored to quantify the plan- and case-specific 
likelihood of interplay-induced dose deviations. For the 
assessment of interplay effects we introduce a random 
breathing states (rand. breath. states) assignment based 
on a subsecond time resolution of the 4D MC dose 
calculation. The presented and evaluated approach 
includes a statistical worst-case approximation to all 
possible breathing curves. 
Material and Methods  
The developed workflow combines MC dose calculation 
with Elekta’s Delivery Parameter Log Files and dose 
accumulation based on 4D-CT images. Treatment plan 
fragments of 0.2s duration are retrieved from linac log 
data and are forward calculated on ten 4D-CT phases 
using MCverify/Hyperion V2.4 (research version of 
Monaco 3.2, Elekta). The resulting dose fragments allow 
simulation of arbitrary respiratory curves (e.g. different 
respiration patterns in phase or frequency as well as 
random breathing states) with a resolution of 0.2s by 
assigning every fragment to a distinct 4D-CT phase. Based 
on deformable image registration (plastimatch) the 
selected dose fragments are accumulated by AVID, a 
software framework for medical data processing. In 
addition to the recorded, normalized breathing curve of 
the patient with random start phases (rand. start), a 
statistical approach is implemented that randomly assigns 
every 0.2s treatment plan fragment to a 4D-CT phase 
(rand. breath. states). 
Results  
Fig. 1 shows our rand. breath. states approach for an 
exemplary 3 Gy, VMAT, SBRT treatment of a 9cm3 lung 
tumor with 1.6cm crano-caudal movement. 128 random 
